A new promising therapeutic approach for PSP is OGA inhibition: Pharmacological blockade of OGA would result in an increase of soluble glycosylated tau, inhibiting the formation of pathological tangles. This evidence concerns the gene MAPT and supranuclear palsy, progressive, 1.